Legal filings and news reports

Study of 99 Million Vaccinated Finds 610% Increased Myocarditis Risk and Other Adverse Events Post mRNA COVID-19 Vaccines

Jan 14, 2025, 03:43 PM

A large-scale study involving 99 million vaccinated individuals has confirmed an increased risk of adverse events following mRNA-based COVID-19 vaccinations, including a 610% increased risk of myocarditis. Additionally, a descriptive analysis of 241 individuals who self-reported a post-vaccination syndrome (PVS) after receiving the COVID-19 vaccine showed that the most common symptoms were exercise intolerance (71%), excessive fatigue (69%), numbness (63%), brain fog (63%), and neuropathy (63%). These individuals reported a median of 20 symptoms and tried a median of 20 treatments, indicating a significant health burden. The study also highlighted the detection of recombinant spike protein in the plasma of vaccinated individuals, suggesting systemic distribution of the vaccine's components. Furthermore, research has indicated that mRNA vaccines may impair innate immunity by suppressing type I interferon responses and could potentially increase the risk of infectious diseases and cancer due to disturbances in regulatory control of protein synthesis and cancer surveillance.